Skip to main content

Market Overview

Salesforce, AbbVie, Intuitive Surgical And An Industrial Stock On CNBC's 'Final Trades'

Share:
Salesforce, AbbVie, Intuitive Surgical And An Industrial Stock On CNBC's 'Final Trades'

On CNBC's “Halftime Report Final Trades,” Joshua Brown, CEO and co-founder, Ritholtz Wealth Management, said he is staying long on 3M Company (NYSE:MMM).

Supporting his view, 3M reported better-than-expected first-quarter financial results on Tuesday. The company reported net sales of $5.95 billion, a 1.0% decline year-over-year (Y/Y), beating the consensus of $ 5.78 billion. Adjusted EPS was $1.88, up 10% Y/Y, beating the consensus of $1.77.

Jim Lebenthal of Cerity Partners picked AbbVie Inc. (NYSE:ABBV) as his final trade.

Lending support to his choice, Cantor Fitzgerald analyst Carter Gould initiated coverage of AbbVie on Tuesday with an Overweight rating and a price target of $210.

Don't forget to check out our premarket coverage here

Rob Sechan of New Edge Capital Group named Salesforce, Inc. (NYSE:CRM) as his final trade.

Guggenheim analyst John Difucci upgraded Salesforce from Sell to Neutral on Monday.

Stephanie Link of Hightower picked Intuitive Surgical, Inc. (NASDAQ:ISRG) as her final trade.

On the earnings front, Intuitive Surgical reported first-quarter revenue of $2.25 billion on Tuesday, beating analyst estimates of $2.19 billion. The robotic-assisted surgery company reported first-quarter adjusted earnings of $1.81 per share, beating analyst estimates of $1.72 per share.

Price Action:

  • 3M shares jumped 8.1% to close at $136.33 on Tuesday.
  • AbbVie gained 2.1% to close at $173.78 during Tuesday's session.
  • Salesforce shares rose 3% to close at $243.39 on Tuesday.
  • Intuitive Surgical shares climbed 2.2% to settle at $478.74 during the session.

Check This Out:

Photo: Shutterstock

 

Related Articles (CRM + ABBV)

View Comments and Join the Discussion!

Posted-In: CNBC Halftime Report Final Trades Jim LebenthalLong Ideas News Markets Media Trading Ideas

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com